The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition

被引：0
|
作者：
Chander Peddaboina
Daniel Jupiter
Steven Fletcher
Jeremy L Yap
Arun Rai
Richard P Tobin
Weihua Jiang
Philip Rascoe
M Karen Newell Rogers
W Roy Smythe
Xiaobo Cao
机构：
[1] The Texas A&M University System,Department of Surgery, Scott & White Memorial Hospital and Clinic
[2] Health Science Center,Department of Pharmaceutical Sciences
[3] College of Medicine,undefined
[4] University of Maryland School of Pharmacy,undefined
[5] Boston University School of Medicine,undefined
来源：
BMC Cancer | / 12卷
关键词：
Mcl-1; Bcl-xL; USP9X; Ubiquitination; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL
    Ingela B Vikström
    Anne Slomp
    Emma M Carrington
    Laura M Moesbergen
    Catherine Chang
    Gemma L Kelly
    Stefan P Glaser
    J H Marco Jansen
    Jeanette H W Leusen
    Andreas Strasser
    David C S Huang
    Andrew M Lew
    Victor Peperzak
    David M Tarlinton
    Cell Death & Disease, 2016, 7 : e2345 - e2345
  • [32] Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells
    Siti Fairus Abdul Rahman
    Azali Azlan
    Kwok-Wai Lo
    Ghows Azzam
    Nethia Mohana-Kumaran
    Discover Oncology, 13
  • [33] Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
    Melvold, Katrine
    Giliberto, Mariaserena
    Karlsen, Linda
    Ayuda-Duran, Pilar
    Hanes, Robert
    Holien, Toril
    Enserink, Jorrit
    Brown, Jennifer R.
    Tjonnfjord, Geir E.
    Tasken, Kjetil
    Skanland, Sigrid S.
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1153 - 1170
  • [34] Importance of Mcl-1 and the Mcl-1-modulating enzyme USP9x for radiosensitivity in prostate cancer cells
    Rudner, J.
    Hogh-Binder, S. A.
    Wolfsperger, F.
    Huber, S.
    Jendrossek, V.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S225 - S226
  • [35] BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells
    Perri, Mariarita
    Yap, Jeremy L.
    Yu, Jianshi
    Cione, Erika
    Fletcher, Steven
    Kane, Maureen A.
    EXPERIMENTAL CELL RESEARCH, 2014, 327 (02) : 183 - 191
  • [36] BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-XL
    Greaves, Georgia
    Milani, Mateus
    Butterworth, Michael
    Carter, Rachel J.
    Byrne, Dominic P.
    Eyers, Patrick A.
    Luo, Xu
    Cohen, Gerald M.
    Varadarajan, Shankar
    CELL DEATH AND DIFFERENTIATION, 2019, 26 (06): : 1037 - 1047
  • [37] Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells
    Rahman, Siti Fairus Abdul
    Azlan, Azali
    Lo, Kwok-Wai
    Azzam, Ghows
    Mohana-Kumaran, Nethia
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [38] BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-XL
    Georgia Greaves
    Mateus Milani
    Michael Butterworth
    Rachel J. Carter
    Dominic P. Byrne
    Patrick A. Eyers
    Xu Luo
    Gerald M. Cohen
    Shankar Varadarajan
    Cell Death & Differentiation, 2019, 26 : 1037 - 1047
  • [39] The discovery of small molecule chemical probes of Bcl-XL and Mcl-1
    Prakesch, Michael
    Denisov, Alexey Yu
    Naim, Marwen
    Gehring, Kalle
    Arya, Prabhat
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (15) : 7443 - 7449
  • [40] Mcl-1 and Bcl-xL are essential for survival of the developing nervous system
    Lauren C. Fogarty
    Robert T. Flemmer
    Brittany A. Geizer
    Maria Licursi
    Ahila Karunanithy
    Joseph T. Opferman
    Kensuke Hirasawa
    Jacqueline L. Vanderluit
    Cell Death & Differentiation, 2019, 26 : 1501 - 1515
12345